Skip navigation

Radiation-activated antitumor vectors

Radiation-activated antitumor vectors

Scott, Simon D. and Marples, Brian (2004) Radiation-activated antitumor vectors. In: Springer, Caroline J., (ed.) Suicide Gene Therapy: methods and reviews. Methods in Molecular Medicine (90). Humana Press Inc., New Jersey, USA, pp. 389-402. ISBN 978-0-89603-971-1 (Print), 978-1-59259-429-0 (Online) ISSN 1543-1894 (doi:10.1385/1-59259-429-8:389)

Full text not available from this repository.

Abstract

Radiotherapy (RT) is a primary treatment modality for the majority of solid tumors. The objective is to destroy the tumor mass by exposure to ionizing radiation (IR) from an external beam or isotopic source. IR causes DNA damage directly and indirectly via the production of reactive oxygen intermediates (ROIs). Accumulation of sufficient damage leads to tumor cell death. The efficacy of RT is usually governed by the radiation dose given, the main limitation being the need to avoid injury to the surrounding normal tissues. To address the latter problem, physical techniques such as conformal and intensity-modulated radiotherapy have been developed to improve the precision of dose delivery to the tumor volume. However, some tumors prove refractory to conventional radiotherapy treatments, as insufficient dose can be delivered to the tumor. In such cases, other therapeutic strategies, such as chemotherapy, can be used in combination, particularly if such drugs lead to increased tumor radiosensitization. Nevertheless, many tumor types, (e.g., glioblastoma) are often resistant to even these combined approaches. Consequently, there is a need for new strategies that can improve the effectiveness of current radiotherapy regimens. Gene therapy offers the exciting possibility of significantly improving the efficacy of radiotherapy without the need for IR-dose escalation or undue increases in normal tissue morbidity. Furthermore, the potential to spatially and temporally target the activation of gene therapy vectors using clinically relevant IR doses provides a particularly attractive prospect.

Item Type: Book Section
Additional Information: [1] Chapter 20. [2] Also, ISSN 1543-1894.
Uncontrolled Keywords: gene therapy, radiotherapy, tumor
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
R Medicine > RS Pharmacy and materia medica
T Technology > TP Chemical technology
Faculty / Department / Research Group: Faculty of Engineering & Science > Medway School of Pharmacy
Related URLs:
Last Modified: 20 Aug 2012 14:38
Selected for GREAT 2016: None
Selected for GREAT 2017: None
Selected for GREAT 2018: None
URI: http://gala.gre.ac.uk/id/eprint/8449

Actions (login required)

View Item View Item